MedTrace Logo

Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow

NCT03393871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-07-24

No results posted yet for this study

Summary

The background for performing the present study is to compare the mass calculations by CT scanning and by invasive absolute blood flow measurements and thereby corroborating both methods.

Conditions

Interventions

DIAGNOSTIC_TEST

absolute blood flow measurement

Absolute maximum flow will be measured, using the RayFlow® multifunctional monorail infusion catheter. (This measurement takes a few minutes per artery, does not require any additional drug, but only 50-100 ml of saline per artery, and is not associated with any additional risk for the patient compared to the regular invasive procedure.

Sponsors & Collaborators

  • Catharina Ziekenhuis Eindhoven

    lead OTHER

Principal Investigators

  • Nico HJ Pijls, MD, PhD · Catharina Ziekenhuis Eindhoven

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-12-01
Completion
2019-03-01
FDA Device
Yes

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03393871 on ClinicalTrials.gov